Enovix (NASDAQ: ENVXW) updates investor presentation post warrant dividend

Rhea-AI Filing Summary

Enovix Corporation filed a current report to share that it has updated its investor presentation following the conclusion of its warrant dividend financing. The revised materials are furnished as Exhibit 99.1 and dated September 2025, giving investors an updated overview of the company and the recent financing structure.

The investor presentation is provided under Regulation FD as “furnished,” not “filed,” which means it is not subject to certain liability provisions under the Exchange Act and the Securities Act, nor automatically incorporated into other SEC filings unless specifically referenced.

0001828318False00018283182025-09-092025-09-09

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 9, 2025

Enovix Corporation

(Exact Name of Registrant as Specified in Its Charter)

Delaware

001-39753

85-3174357

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

3501 W Warren Avenue Fremont, California						94538
(Address of Principal Executive Offices)						(Zip Code)

Registrant’s Telephone Number, Including Area Code: (510) 695-2350

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

ENVX

The Nasdaq Global Select Market

Warrants, each exercisable for one share of Common Stock, at an exercise price of $8.75 per share

ENVXW

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 7.01 Regulation FD Disclosure.

Following the conclusion of its warrant dividend financing, Enovix Corporation updated its investor presentation furnished with this Current Report as Exhibit 99.1. Exhibit 99.1 is incorporated into this Item 7.01 by reference.

The information furnished in this Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or subject to the liabilities of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and shall not be incorporated by reference in any registration statement or other document filed under the Securities Act or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number						Description
99.1						Investor Presentation dated September 2025
104						Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

									Enovix Corporation
Date:			September 9, 2025			By:			/s/ Arthi Chakravarthy
									Arthi Chakravarthy Chief Legal Officer and Head of Corporate Development

FAQ

What did Enovix (ENVXW) disclose in this 8-K filing?

Enovix Corporation furnished an updated investor presentation as Exhibit 99.1, prepared after the conclusion of its warrant dividend financing.

Why did Enovix update its investor presentation?

The company updated its investor presentation following the completion of its warrant dividend financing, reflecting the latest information for investors.

How is the Enovix investor presentation treated under securities laws?

The presentation is furnished under Regulation FD, not filed, so it is not subject to Section 18 liability and is not incorporated into other filings unless specifically referenced.

What exhibit was included with Enovix’s 8-K for ENVXW?

The filing includes Exhibit 99.1, an investor presentation dated September 2025, and Exhibit 104, the cover page interactive data file.

Who signed the Enovix 8-K related to the investor presentation?

The report was signed on behalf of Enovix Corporation by Arthi Chakravarthy, Chief Legal Officer and Head of Corporate Development.

Does the Enovix investor presentation automatically become part of future SEC filings?

No. The presentation will only be incorporated into other SEC documents if specifically referenced in those filings.